Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001236447-26-000003

Options or other derivatives

  • Director acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
SCHIMMEL PAUL Director 2026-05-11 Grant or award · Stock Option (right to buy) +50,000 50,000 D: show line 1 in the form
Loading xslF345X06/ownership.xml…